Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.995 EUR | +1.02% | +5.85% | -9.55% |
03-28 | PT Gudang Garam Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | PT Gudang Garam Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 324.5 for the 2024 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.55% | 2.25B | - | ||
+14.08% | 78.75B | B- | ||
-6.63% | 64.01B | B | ||
+20.77% | 50.39B | A- | ||
+3.68% | 7.48B | A- | ||
-13.41% | 5.63B | A- | ||
+6.75% | 2.63B | C- | ||
-32.16% | 1.64B | - | ||
-19.01% | 1.1B | D+ | ||
0.00% | 1.03B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- GGRM Stock
- GGG Stock
- Ratings PT Gudang Garam Tbk